uk broker tips increased relenza revenue, page-7

To be fair the analysts have picked Biota well in terms of a buy rating with some even pointing out the crazy discount to cash backing it was trading at. But I've seen analysts stick there neck out down under and get them chopped off... I remember seeing a very low valuation on AMP shortly after it was floated... the analyst got hammered but still eventually picked it correctly.

Imagine when BTA was at 30c if an analyst had a price target of $10... I know I did but I'm no analyst.